PLoS ONE, 2012 · DOI: 10.1371/journal.pone.0039500 · Published: June 20, 2012
This study investigates the potential of mesenchymal stem cells (MSCs) to improve functional recovery after spinal cord injury (SCI) in adult rats. The researchers grafted MSCs intravenously after a spinal cord compression injury and assessed their impact on functional recovery and the underlying mechanisms of action. The findings suggest that MSCs promote recovery through their secretions, influencing neurotrophic and pro-angiogenic processes, rather than by integrating into the host tissue.
MSCs offer a promising therapeutic approach for spinal cord injury due to their ability to promote functional recovery.
The study underscores the importance of paracrine signaling in MSC-mediated repair, suggesting strategies to enhance secretion of beneficial factors.
Intravenous delivery of MSCs is a safe and less invasive method for treating spinal cord injury, facilitating clinical translation.